J
Jan C.L. Wesdorp
Publications - 2
Citations - 258
Jan C.L. Wesdorp is an academic researcher. The author has contributed to research in topics: TIMI & Cmax. The author has an hindex of 2, co-authored 2 publications receiving 258 citations.
Papers
More filters
Journal ArticleDOI
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
Elliott M. Antman,Hans W. Louwerenburg,Hubert F. Baars,Jan C.L. Wesdorp,Bas Hamer,Jean-Pierre Bassand,Frederique Bigonzi,Ghislaine Pisapia,C. Michael Gibson,Hein Heidbuchel,Eugene Braunwald,Frans Van de Werf +11 more
TL;DR: In this paper, the authors evaluated enoxaparin with full-dose tenecteplase (TNK) and half-dose TNK plus abciximab.
Journal ArticleDOI
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.
C. Michael Gibson,Cafer Zorkun,Peter Molhoek,Krzysztof Zmudka,Mark Greenberg,Hiltrud S. Mueller,Jan C.L. Wesdorp,Hans W. Louwerenburg,Alan Niederman,Jaap Westenburg,Mahesh Bikkina,John Batty,Jobst De Winter,Sabina A. Murphy,Carolyn H. McCabe +14 more
TL;DR: In a dose escalation study of a single intravenous bolus, the novel fibrinolytic agent, BB-10153 was associated with a rise in the mean area under the curve and Cmax for drug concentration over the dose range 1 to 10 mg/kg.